The use of 2-[18F]fluoro-2-deoxy-d-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography
- 1 February 1992
- journal article
- Published by Elsevier in International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology
- Vol. 19 (2), 183-190
- https://doi.org/10.1016/0883-2897(92)90006-k
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- High [18F]-Fluorodeoxyglucose Uptake in Abdominal AbscessesJournal of Computer Assisted Tomography, 1989
- Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages.Journal of Clinical Investigation, 1989
- In-Vivo Measurement of the Local Metabolic Response to Lung Inflammation in Rabbits by Positron Emission Tomography (PET)Clinical Science, 1989
- The development of a clinical protocol for the radiolabelling of mixed leucocytes with 99Tcm-hexamethylpropyleneamine oximeNuclear Medicine Communications, 1988
- Inflammation: imaging with Tc-99m HMPAO-labeled leukocytes.Radiology, 1988
- Optimum conditions for radiolabelling human granulocytes and mixed leucocytes with 111In-tropolonateEuropean Journal of Nuclear Medicine and Molecular Imaging, 1988
- [3] Basic methods for the study of phagocytosisMethods in Enzymology, 1986
- The labelling of blood cells in plasma with111In-tropolonateThe British Journal of Radiology, 1982
- THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT1Journal of Neurochemistry, 1977